about
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision d...
Read More
4.30
0.03
(0.70%)
428.7K
XNAS Volume
XNAS 10 Sep, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Alumis Inc. is on 16 Sep 2025 for the purpose of Stifel 2025 Virtual Immunology & Inflammation Forum
See details
Not Eligible
Expensive Valuation
Technically Neutral
Alumis Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..